T. Slobodin

Clinical rationale for the optimal therapeutic window for deep brain stimulation in Parkinsonʼs disease

Background. Parkinsonʼs disease remains one of the most rapidly progressive neurodegenerative disorders, leading to early disability and a substantial decline in patient quality of life. Although pharmacotherapy provides high efficacy in the initial stages, long-term levodopa therapy inevitably results in motor fluctua...